Blog Archives

ISPOR COMMENTS ON PROPOSED EUROPEAN UNION COOPERATION ON HEALTH TECHNOLOGY ASSESSMENT

Society’s Comments Emphasize Need for Ongoing Collaboration and Observation of HTA Good Practices   Princeton, NJ—January 24, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has submitted comments in response to the European Commission’s request for public consultation regarding

Tagged with: , , ,
Posted in Announcements, ISPOR News & Press

ISPOR 19th ANNUAL EUROPEAN CONGRESS DREW KEY STAKEHOLDERS AND THOUGHT LEADERS TO DISCUSS ACCESS TO MEDICAL INNOVATIONS

ISPOR 19th Annual European Congress

Regulatory, Policy, and Financing Decisions in International Health Systems   Princeton, NJ—November 22, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recently concluded its 19th Annual European Congress in Vienna, Austria. More than 4,700 delegates—stakeholders from all sectors of

Tagged with: , , , , , , , ,
Posted in Announcements, ISPOR News & Press

ISPOR 19TH ANNUAL EUROPEAN CONGRESS FOCUSES ON THE USE OF REAL-WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENT

Vienna, Austria—2 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held an issue panel this afternoon entitled, Using Observational (Real-World) Data in Health Technology Assessment: Route to Confusion or Better Decisions? The session took place at the Society’s

Tagged with: , , , ,
Posted in Announcements, ISPOR News & Press

ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXAMINES INCLUSION OF FUTURE MEDICAL COSTS IN HEALTH TECHNOLOGY ASSESSMENT GUIDELINES

Vienna, Austria—2 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held an issue panel entitled, Should Health Technology Assessment Guidelines Recommend Inclusion of Future Medical Costs?, at the Society’s 19th Annual European Congress in Vienna, Austria. 

Tagged with: , ,
Posted in Announcements, ISPOR News & Press

ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXAMINES USE OF MULTI-CRITERIA DECISION ANALYSIS TO SUPPORT HEALTH TECHNOLOGY ASSESSMENT

Vienna, Austria—1 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a workshop this morning entitled, The Potential and Pitfalls of Using Multi-Criteria Decision Analysis to Support Health Technology Assessment. The session took place at the Society’s 19th

Tagged with: , , , ,
Posted in Announcements, ISPOR News & Press

ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXPLORES EUROPEAN COOPERATION IN HEALTH TECHNOLOGY ASSESSMENT

Vienna, Austria—31 October 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR)  facilitated a discussion on National Health Technology Assessment (HTA) Process and European Cooperation on HTA: Fit for Purpose? this morning at the Society’s 19th Annual European Congress in

Tagged with: , ,
Posted in Announcements, ISPOR News & Press

PLENARY 1 OF ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXPLORES SYNERGIES IN HEALTH CARE

Plenary 1_Eichler_DSC_8259

Building Collaboration Between Regulators and Health Technology Assessment Bodies  Vienna, Austria—31 October 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) opened its 19th Annual European Congress in Vienna, Austria this morning with the first plenary session, What Synergies Could

Tagged with: , , ,
Posted in Announcements, ISPOR News & Press

ISPOR 19TH ANNUAL EUROPEAN CONGRESS TO FOCUS ON MANAGING ACCESS TO MEDICAL INNOVATION

ISPOR Vienna 2016_Banner

Congress Scheduled for 29 October-2 November 2016 in Vienna Princeton, NJ—October 17, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced confirmation of the scientific sessions for its 19th Annual European Congress that will begin next week, 29 October-2

Tagged with: , , , , , , ,
Posted in Announcements, ISPOR News & Press

ACCOUNTING FOR FUTURE PRICE REDUCTIONS CAUSED BY INCREASING ADOPTION OF MEDICAL DEVICES: IMPACT ON HTAs

Value in Health - Sept-Oct 2016

Future Changes in Price and Uptake Affect Cost-Effectiveness Results  Princeton, NJ—October 10, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of a report detailing a new modeling approach that explores the health technology assessment (HTA)

Tagged with: , , ,
Posted in Announcements, ISPOR News & Press, Value in Health

ISPOR ANNOUNCES PLENARY SESSIONS AND SPEAKERS FOR 19TH ANNUAL EUROPEAN CONGRESS

ISPOR Vienna 2016_Banner

To Be Held 29 October–2 November 2016 in Vienna, Austria  Princeton, NJ—September 12, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced plenary sessions and speakers for its 19th Annual European Congress that will be held 29 October–2 November

Tagged with: , , , , , , , ,
Posted in Announcements, ISPOR News & Press
Categories
Follow ISPOR
RSS FeedFriend me on FacebookFollow my company on LinkedInFollow me on TwitterWatch me on YouTube